Literature DB >> 22920909

Gene carrier showing all-or-none response to cancer cell signaling.

Riki Toita1, Jeong-Hun Kang, Tetsuro Tomiyama, Chan Woo Kim, Shujiro Shiosaki, Takuro Niidome, Takeshi Mori, Yoshiki Katayama.   

Abstract

In this work we designed a novel nano carrier, a linear polyethylenimine (LPEI)-peptide conjugate, for cancer-specific expression of transgenes. The conjugate was easily synthesized by using a click chemistry scheme orthogonal to the reactive side groups of the peptide, which is the substrate of protein kinase Cα (PKCα). Polyplexes of the conjugates with plasmid DNA (pDNA) were intact and stably dispersed even in the presence of cell lysate. Despite this stability, the polyplexes readily dissociated upon phosphorylation of the grafted peptides by PKCα. Because of its endosomal escape ability and adequate susceptibility to PKCα, the polyplexes showed an all-or-none type response to PKCα activity in transgene expression in vitro. The polyplexes achieved cancer tissue-specific transgene expression even for a tumor with a relatively low PKCα activity. Thus the LPEI-peptide conjugate has high potential as a nanocarrier for cancer-targeted gene therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22920909     DOI: 10.1021/ja305437n

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

Review 1.  Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

Authors:  Riki Toita; Takahito Kawano; Jeong-Hun Kang; Masaharu Murata
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

2.  Biological evaluation of protein nanocapsules containing doxorubicin.

Authors:  Riki Toita; Masaharu Murata; Kana Abe; Sayoko Narahara; Jing Shu Piao; Jeong-Hun Kang; Kenoki Ohuchida; Makoto Hashizume
Journal:  Int J Nanomedicine       Date:  2013-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.